Evidence map›Paper›PMID 26376930›Full record

ArticleClinical and vaccine immunology : CVI2016

Human Memory CD4+ T Cell Immune Responses against Giardia lamblia.

Christina Skår Saghaug, Steinar Sørnes, Dimitra Peirasmaki, Staffan Svärd, Nina Langeland, Kurt Hanevik

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 59 citations in OpenAlex.

  1. Extracellular Vesicles ofJournal of extracellular biology · 2026
    Article
  2. Article
  3. T cell exhaustion inParasite epidemiology and control · 2026
    Review
  4. Unraveling the Potential ofPharmaceutics · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. The Influence of the ProtozoanInternational journal of molecular sciences · 2024
    Review
  9. Article
  10. bioRxiv : the preprint server for biology · 2024
    Article
  11. Current Understanding ofCurrent tropical medicine reports · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. The Giardial Arginine Deiminase Participates inInternational journal of molecular sciences · 2022
    Article
  16. Influence ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  17. Frontiers in cellular and infection microbiology · 2022
    Article
  18. Review
  19. Mucosal Defense AgainstFrontiers in immunology · 2022
    Review
  20. Infection and drug resistance · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Christina Skår SaghaugNational Centre for Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway Department of Clinical Science, University of Bergen, Bergen, Norway christina.saghaug@uib.no.ORCID http://orcid.org/0000-0003-0836-7889
Steinar SørnesDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Dimitra PeirasmakiDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Staffan SvärdDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Nina LangelandNational Centre for Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway Department of Clinical Science, University of Bergen, Bergen, Norway.
Kurt HanevikNational Centre for Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-1466-2326
Haukeland University Hospital · NOUppsala University · SEUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal protozoan parasite Giardia lamblia may cause severe prolonged diarrheal disease or pass unnoticed as an asymptomatic infection. T cells seem to play an important role in the immune response to Giardia infection, and memory responses may last years. Recently, TH17 responses have been found in three animal studies of Giardia infection. The aim of this study was to characterize the human CD4(+) T cell responses to Giardia. Peripheral blood mononuclear cells (PBMCs) were obtained from 21 returning travelers with recent or ongoing giardiasis and 12 low-risk healthy controls and stimulated in vitro with Giardia lamblia proteins. Production of tumor necrosis factor alpha (TNF-α), gamma interferon, interleukin-17A (IL-17A), IL-10, and IL-4 was measured in CD4(+) effector memory (EM) T cells after 24 h by flow cytometry. After 6 days of culture, activation and proliferation were measured by flow cytometry, while an array of inflammatory cytokine levels in supernatants were measured with multiplex assays. We found the number of IL-17A-producing CD4(+) EM T cells, as well as that of cells simultaneously producing both IL-17A and TNF-α, to be significantly elevated in the Giardia-exposed individuals after 24 h of antigen stimulation. In supernatants of PBMCs stimulated with Giardia antigens for 6 days, we found inflammation-associated cytokines, including 1L-17A, as well as CD4(+) T cell activation and proliferation, to be significantly elevated in the Giardia-exposed individuals. We conclude that symptomatic Giardia infection in humans induces a CD4(+) EM T cell response of which IL-17A production seems to be an important component.

Indexed as

Immunologic MemoryLymphocyte ActivationAdolescentAdultAntigens, ProtozoanCD4-Positive T-LymphocytesCytokinesFemaleFlow CytometryGiardia lambliaGiardiasisHumansInterferon-gammaInterleukin-17Leukocytes, MononuclearMaleAntigens, ProtozoanCytokinesIL17A protein, humanInterferon-gammaInterleukin-17Tumor Necrosis Factor-alpha

Identifiers

PMID26376930
PMCPMC4711086
OpenAlexW2219988520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.